Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis
Authors:
Open Access
- 1 May 2018
- journal article
- research article
- Vol. 19 (5) , 1169-1173
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapyOncotarget, 2015
- Platinum-based chemotherapy in triple-negative breast cancerAnti-Cancer Drugs, 2015
- Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialThe Lancet Oncology, 2015
- Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancerBreast Cancer Research and Treatment, 2015
- Efficacy of platinum-based chemotherapy in triple-negative breast cancer patients with metastases confined to the lungsAnti-Cancer Drugs, 2014
- Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progressionOncology Letters, 2014
- Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysisOncology Letters, 2012
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast CancerJournal of Clinical Oncology, 2012
- Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experienceAnnals of Oncology, 2010
- Operating Characteristics of a Rank Correlation Test for Publication Bias1994